Skip to main content
SpringerLink
Log in

Epidemiology of HPV in Head and Neck Cancer: Variant Strains, Discrete Protein Function

  • Chapter
  • First Online:
Molecular Determinants of Head and Neck Cancer

Part of the book series: Current Cancer Research ((CUCR))

Abstract

Human papillomavirus (HPV) infection has emerged as a major causative agent for cancers of the head and neck. HPV-positive cancers of the oropharynx are associated with better survival rates than HPV-negative cancers of the oropharynx, which appears likely to be associated with differences in the biology of the two diseases. We will discuss the role of HPV-encoded proteins in host infection and carcinogenesis. HPV infection is increasing worldwide, with recent data showing a dramatic increase in HPV-associated oropharyngeal head and neck cancer incidence, and contrasting infection rates in developed and developing nations. Finally, we will review the emerging biology of intratypic variants of HPV, with different variants associated with different potential for malignancy, and suggest potential areas of further study.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. zur Hausen H, de Villiers EM. Human papillomaviruses. Ann Rev Microbiol. 1994;48:427–47.

    Google Scholar 

  2. Syrjanen K, Syrjanen S, Lamberg M, Pyrhonen S, Nuutinen J. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg. 1983;12:418–24.

    PubMed  CAS  Google Scholar 

  3. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709–20.

    PubMed  CAS  Google Scholar 

  4. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14:467–75.

    PubMed  CAS  Google Scholar 

  5. Shindoh M, Chiba I, Yasuda M, Saito T, Funaoka K, Kohgo T, Amemiya A, Sawada Y, Fujinaga K. Detection of human papillomavirus DNA sequences in oral squamous cell carcinomas and their relation to p53 and proliferating cell nuclear antigen expression. Cancer. 1995;76:1513–21.

    PubMed  CAS  Google Scholar 

  6. Haraf DJ, Nodzenski E, Brachman D, Mick R, Montag A, Graves D, Vokes EE, Weichselbaum RR. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res. 1996;2:755–62.

    PubMed  CAS  Google Scholar 

  7. Paz IB, Cook N, Odom-Maryon T, Xie Y, Wilczynski SP. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer’s tonsillar ring. Cancer. 1997;79:595–604.

    PubMed  CAS  Google Scholar 

  8. Mineta H, Ogino T, Amano HM, Ohkawa Y, Araki K, Takebayashi S, Miura K. Human papilloma virus (HPV) type 16 and 18 detected in head and neck squamous cell carcinoma. Anticancer Res. 1998;18:4765–8.

    PubMed  CAS  Google Scholar 

  9. Adams V, Schmid S, Zariwala M, Schmid M, Kleihues P, Briner J, Schafer R. Prevalence of human papilloma virus DNA in head and neck cancers carrying wild-type or mutant p53 tumor suppressor genes. Anticancer Res. 1999;19:1–6.

    PubMed  CAS  Google Scholar 

  10. Nishioka S, Fukushima K, Nishizaki K, Gunduz M, Tominaga S, Fukazawa M, Monden N, Watanabe S, Masuda Y, Ogura H. Human papillomavirus as a risk factor for head and neck cancers—a case-control study. Acta Otolaryngol Suppl. 1999;540:77–80.

    PubMed  CAS  Google Scholar 

  11. Badaracco G, Venuti A, Morello R, Muller A, Marcante ML. Human papillomavirus in head and neck carcinomas: prevalence, physical status and relationship with clinical/pathological parameters. Anticancer Res. 2000;20:1301–5.

    PubMed  CAS  Google Scholar 

  12. Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer. 2000;89:300–4.

    PubMed  CAS  Google Scholar 

  13. Sisk EA, Bradford CR, Jacob A, Yian CH, Staton KM, Tang G, Harris MO, Carey TE, Lancaster WD, Gregoire L. Human papillomavirus infection in “young” versus “old” patients with squamous cell carcinoma of the head and neck. Head Neck. 2000;22:649–57.

    PubMed  CAS  Google Scholar 

  14. Venuti A, Manni V, Morello R, De Marco F, Marzetti F, Marcante ML. Physical state and expression of human papillomavirus in laryngeal carcinoma and surrounding normal mucosa. J Med Virol. 2000;60:396–402.

    PubMed  CAS  Google Scholar 

  15. Klussmann JP, Weissenborn SJ, Wieland U, Dries V, Kolligs J, Jungehuelsing M, Eckel HE, Dienes HP, Pfister HJ, Fuchs PG. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer. 2001;92:2875–84.

    PubMed  CAS  Google Scholar 

  16. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer. 2001;92:805–13.

    PubMed  CAS  Google Scholar 

  17. Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982–1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:622–35.

    PubMed  CAS  Google Scholar 

  18. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Youngman L, Lehtinen M, Dillner J. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001;344:1125–31.

    PubMed  CAS  Google Scholar 

  19. Hodge KM, Flynn MB, Drury T. Squamous cell carcinoma of the upper aerodigestive tract in nonusers of tobacco. Cancer. 1985;55:1232–5.

    PubMed  CAS  Google Scholar 

  20. Hoshikawa T, Nakajima T, Uhara H, Gotoh M, Shimosato Y, Tsutsumi K, Ono I, and Ebihara S Detection of human papillomavirus DNA in laryngeal squamous cell carcinomas by polymerase chain reaction. Laryngoscope. 1990;100:647–50.

    Google Scholar 

  21. Niedobitek G, Pitteroff S, Herbst H, Shepherd P, Finn T, Anagnostopoulos I, Stein H. Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil. J Clin Pathol. 1990;43:918–21.

    PubMed Central  PubMed  CAS  Google Scholar 

  22. Blot WJ, Devesa SS, McLaughlin JK, Fraumeni JF Jr. Oral and pharyngeal cancers. Cancer Surv. 1994;19–20:23–42.

    PubMed  Google Scholar 

  23. Ostwald C, Muller P, Barten M, Rutsatz K, Sonnenburg M, Milde-Langosch K, Loning T. Human papillomavirus DNA in oral squamous cell carcinomas and normal mucosa. J Oral Pathol Med. 1994;23:220–5.

    PubMed  CAS  Google Scholar 

  24. Sethi S, Ali-Fehmi R, Franceschi S, Struijk L, Van Doorn LJ, Quint W, Albashiti B, Ibrahim M, Kato I. Characteristics and survival of head and neck cancer by HPV status: a cancer registry-based study. Int J Cancer. 2012;131:1179–86.

    PubMed Central  PubMed  CAS  Google Scholar 

  25. Burk RD, Chen Z, van Doorslaer K. Human papillomaviruses: genetic basis of carcinogenicity. Public Health Genomics. 2009;12:281–90.

    PubMed Central  PubMed  Google Scholar 

  26. Kines RC, Thompson CD, Lowy DR, Schiller JT, Day PM. The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Proc Natl Acad Sci U.S.A. 2009;106:20458–63.

    CAS  Google Scholar 

  27. Schiller JT, Day PM, Kines RC. Current understanding of the mechanism of HPV infection. Gynecol Oncol. 2010;118:S12–17.

    PubMed Central  PubMed  CAS  Google Scholar 

  28. McBride AA, Oliveira JG, McPhillips MG. Partitioning viral genomes in mitosis: same idea, different targets. Cell Cycle. 2006;5:1499–502.

    PubMed  CAS  Google Scholar 

  29. Munger K, Baldwin A, Edwards KM, Hayakawa H, Nguyen CL, Owens M, Grace M, Huh K. Mechanisms of human papillomavirus-induced oncogenesis. J Virol. 2004;78:11451–60.

    PubMed Central  PubMed  Google Scholar 

  30. Ma T, Zou N, Lin BY, Chow LT, Harper JW. Interaction between cyclin-dependent kinases and human papillomavirus replication-initiation protein E1 is required for efficient viral replication. Proc Natl Acad Sci U.S.A. 1999;96:382–7.

    CAS  Google Scholar 

  31. Liu JS, Kuo SR, Makhov AM, Cyr DM, Griffith JD, Broker TR, Chow LT. Human Hsp70 and Hsp40 chaperone proteins facilitate human papillomavirus-11 E1 protein binding to the origin and stimulate cell-free DNA replication. J Biol Chem. 1998;273:30704–12.

    PubMed  CAS  Google Scholar 

  32. Lee D, Sohn H, Kalpana GV, Choe J. Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA. Nature. 1999;399:487–91.

    PubMed  CAS  Google Scholar 

  33. Swindle CS, Engler JA. Association of the human papillomavirus type 11 E1 protein with histone H1. J Virol. 1998;72:1994–2001.

    PubMed Central  PubMed  CAS  Google Scholar 

  34. Yasugi T, Vidal M, Sakai H, Howley PM, Benson JD. Two classes of human papillomavirus type 16 E1 mutants suggest pleiotropic conformational constraints affecting E1 multimerization, E2 interaction, and interaction with cellular proteins. J Virol. 1997;71:5942–51.

    PubMed Central  PubMed  CAS  Google Scholar 

  35. Lin BY, Makhov AM, Griffith JD, Broker TR, Chow LT. Chaperone proteins abrogate inhibition of the human papillomavirus (HPV) E1 replicative helicase by the HPV E2 protein. Mol Cell Biol. 2002;22:6592–604.

    PubMed Central  PubMed  CAS  Google Scholar 

  36. Zobel T, Iftner T, Stubenrauch F. The papillomavirus E8-E2C protein represses DNA replication from extrachromosomal origins. Mol Cell Biol. 2003;23:8352–62.

    PubMed Central  PubMed  CAS  Google Scholar 

  37. Stubenrauch F, Zobel T, Iftner T. The E8 domain confers a novel long-distance transcriptional repression activity on the E8E2C protein of high-risk human papillomavirus type 31. J Virol. 2001;75:4139–49.

    PubMed Central  PubMed  CAS  Google Scholar 

  38. Fertey J, Hurst J, Straub E, Schenker A, Iftner T, Stubenrauch F. Growth inhibition of HeLa cells is a conserved feature of high-risk human papillomavirus E8^E2C proteins and can also be achieved by an artificial repressor protein. J Virol. 2011;85:2918–26.

    PubMed Central  PubMed  CAS  Google Scholar 

  39. Doorbar J, Ely S, Sterling J, McLean C, Crawford L. Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature. 1991;352:824–7.

    PubMed  CAS  Google Scholar 

  40. Wang Q, Griffin H, Southern S, Jackson D, Martin A, McIntosh P, Davy C, Masterson PJ, Walker PA, Laskey P, Omary MB, Doorbar J. Functional analysis of the human papillomavirus type 16 E1 = E4 protein provides a mechanism for in vivo and in vitro keratin filament reorganization. J Virol. 2004;78:821–33.

    PubMed Central  PubMed  CAS  Google Scholar 

  41. Conrad M, Bubb VJ, Schlegel R. The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J Virol. 1993;67:6170–8.

    PubMed Central  PubMed  CAS  Google Scholar 

  42. Oetke C, Auvinen E, Pawlita M, Alonso A. Human papillomavirus type 16 E5 protein localizes to the Golgi apparatus but does not grossly affect cellular glycosylation. Arch Virol. 2000;145:2183–91.

    PubMed  CAS  Google Scholar 

  43. DiMaio D, Mattoon D. Mechanisms of cell transformation by papillomavirus E5 proteins. Oncogene. 2001;20:7866–73.

    PubMed  CAS  Google Scholar 

  44. Hafner N, Driesch C, Gajda M, Jansen L, Kirchmayr R, Runnebaum IB, Durst M. Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene. 2008;27:1610–7.

    PubMed  CAS  Google Scholar 

  45. Bouvard V, Matlashewski G, Gu ZM, Storey A, Banks L. The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression. Virology. 1994;203:73–80.

    PubMed  CAS  Google Scholar 

  46. Chang JL, Tsao YP, Liu DW, Huang SJ, Lee WH, Chen SL. The expression of HPV-16 E5 protein in squamous neoplastic changes in the uterine cervix. J Biomed Sci. 2001;8:206–13.

    PubMed  CAS  Google Scholar 

  47. Ashrafi GH, Brown DR, Fife KH, Campo MS. Down-regulation of MHC class I is a property common to papillomavirus E5 proteins. Virus Res. 2006;120:208–11.

    PubMed  CAS  Google Scholar 

  48. Zhang B, Li P, Wang E, Brahmi Z, Dunn KW, Blum JS, Roman A. The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma. Virology. 2003;310:100–8.

    PubMed  CAS  Google Scholar 

  49. Massimi P, Shai A, Lambert P, Banks L. HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background. Oncogene. 2008;27:1800–4.

    PubMed  CAS  Google Scholar 

  50. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 1993;75:495–505.

    PubMed  CAS  Google Scholar 

  51. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990;248:76–9.

    PubMed  CAS  Google Scholar 

  52. Gewin L, Myers H, Kiyono T, Galloway DA. Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. Genes Dev. 2004;18:2269–82.

    PubMed Central  PubMed  CAS  Google Scholar 

  53. Ronco LV, Karpova AY, Vidal M, Howley PM. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 1998;12:2061–72.

    PubMed Central  PubMed  CAS  Google Scholar 

  54. Tong X, Howley PM. The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proc Natl Acad Sci U.S.A. 1997;94:4412–7.

    CAS  Google Scholar 

  55. Boyer SN, Wazer DE, Band V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 1996;56:4620–4.

    PubMed  CAS  Google Scholar 

  56. Khleif SN, DeGregori J, Yee CL, Otterson GA, Kaye FJ, Nevins JR, Howley PM. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci U.S.A. 1996;93:4350–4.

    CAS  Google Scholar 

  57. Dyson N, Guida P, Munger K, Harlow E. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol. 1992;66:6893–902.

    PubMed Central  PubMed  CAS  Google Scholar 

  58. Munger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 1989;8:4099–105.

    PubMed Central  PubMed  CAS  Google Scholar 

  59. Phelps WC, Bagchi S, Barnes JA, Raychaudhuri P, Kraus V, Munger K, Howley PM, Nevins JR. Analysis of trans activation by human papillomavirus type 16 E7 and adenovirus 12S E1A suggests a common mechanism. J Virol. 1991;65:6922–30.

    PubMed Central  PubMed  CAS  Google Scholar 

  60. Arroyo M, Bagchi S, Raychaudhuri P. Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex. Mol Cell Biol. 1993;13:6537–46.

    PubMed Central  PubMed  CAS  Google Scholar 

  61. McIntyre MC, Ruesch MN, Laimins LA. Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107. Virology. 1996;215:73–82.

    PubMed  CAS  Google Scholar 

  62. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244–65.

    PubMed Central  PubMed  CAS  Google Scholar 

  63. Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer–burden and assessment of causality. J Natl Cancer Inst Monogr. 2003;3–13.

    Google Scholar 

  64. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000;92:690–8.

    Google Scholar 

  65. Ragin CC R, Reshmi SC, Gollin SM. Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line. Int J Cancer. 2004;110:701–09.

    PubMed  CAS  Google Scholar 

  66. Wentzensen N, Vinokurova S, von Knebel Doeberitz M. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res. 2004;64:3878–84.

    PubMed  CAS  Google Scholar 

  67. Mellin H, Dahlgren L, Munck-Wikland E, Lindholm J, Rabbani H, Kalantari M, Dalianis T. Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer. 2002;102:152–8.

    PubMed  CAS  Google Scholar 

  68. Deng Z, Hasegawa M, Kiyuna A, Matayoshi S, Uehara T, Agena S, Yamashita Y, Ogawa K, Maeda H, Suzuki M. Viral load, physical status, and E6/E7 mRNA expression of human papillomavirus in head and neck squamous cell carcinoma. Head Neck. 2013;35:800–8.

    Google Scholar 

  69. Badaracco G, Venuti A, Morello R, Muller A, Marcante ML. Human papillomavirus in head and neck carcinomas: prevalence, physical status and relationship with clinical/pathological parameters. Anticancer Res. 2000;20:1301–5.

    PubMed  CAS  Google Scholar 

  70. Badaracco G, Rizzo C, Mafera B, Pichi B, Giannarelli D, Rahimi SS, Vigili MG, Venuti A. Molecular analyses and prognostic relevance of HPV in head and neck tumours. Oncol Rep. 2007;17:931–9.

    PubMed  CAS  Google Scholar 

  71. Koskinen WJ, Chen RW, Leivo I, Makitie A, Back L, Kontio R, Suuronen R, Lindqvist C, Auvinen E, Molijn A, Quint WG, Vaheri A, Aaltonen LM. Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer. 2003;107:401–6.

    Google Scholar 

  72. Watts SL, Brewer EE, Fry TL. Human papillomavirus DNA types in squamous cell carcinomas of the head and neck. Oral Surg Oral Med Oral Pathol. 1991;71:701–7.

    PubMed  CAS  Google Scholar 

  73. Markowitz LE, Sternberg M, Dunne EF, McQuillan G, Unger ER. Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003–2004. J Infect Dis. 2009;200:1059–67.

    PubMed  Google Scholar 

  74. Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, Graubard BI, Chaturvedi AK. Prevalence of oral HPV infection in the United States, 2009–2010. JAMA. 2012;307:693–703.

    PubMed  CAS  Google Scholar 

  75. Safaeian M, Porras C, Schiffman M, Rodriguez AC, Wacholder S, Gonzalez P, Quint W, Van Doorn LJ, Sherman ME, Xhenseval V, Herrero R, Hildesheim A. Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections. J Natl Cancer Inst. 2010;102:1653–62.

    PubMed Central  PubMed  CAS  Google Scholar 

  76. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. 2010. Lyon, France: International Agency for Research on Cancer; 2010. (Ref Type: Generic).

    Google Scholar 

  77. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin K. SEER Cancer Statistics Review, 1975–2009.Bethesda, MD, based on November 2011 SEER data submission, posted to the SEER web site, April 2012: National Cancer Institute, 2012.

    Google Scholar 

  78. Maritz GS, Mutemwa M. Tobacco smoking: patterns, health consequences for adults, and the long-term health of the offspring. Glob J Health Sci. 2012;4:62–75.

    PubMed  Google Scholar 

  79. Roberts JC, Li G, Reitzel LR, Wei Q, Sturgis EM. No evidence of sex-related survival disparities among head and neck cancer patients receiving similar multidisciplinary care: a matched-pair analysis. Clin Cancer Res. 2010;16:5019–27.

    PubMed Central  PubMed  Google Scholar 

  80. Znaor T, Vucemilo L, Kulis T, Znaor A. Incidence and mortality trends of head and neck cancer in Croatia in the period 1988–2008. Acta Otolaryngol. 2013;133(3):305–12.

    PubMed  Google Scholar 

  81. Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, Ahrlund-Richter S, Marklund L, Romanitan M, Lindquist D, Ramqvist T, Lindholm J, Sparen P, Ye W, Dahlstrand H, Munck-Wikland E, Dalianis T. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer. 2009;125:362–6.

    PubMed  Google Scholar 

  82. Gillison ML, Koch WM, Shah KV. Human papillomavirus in head and neck squamous cell carcinoma: are some head and neck cancers a sexually transmitted disease? Curr Opin Oncol. 1999;11:191–9.

    PubMed  CAS  Google Scholar 

  83. Braakhuis BJ, Snijders PJ, Keune WJ, Meijer CJ, Ruijter-Schippers HJ, Leemans CR, Brakenhoff RH. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst. 2004;96:998–1006.

    PubMed  CAS  Google Scholar 

  84. van Houten VM, Snijders PJ, van den Brekel MW, Kummer JA, Meijer CJ, van Leeuwen B, Denkers F, Smeele LE, Snow GB, Brakenhoff RH. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer. 2001;93:232–5.

    PubMed  CAS  Google Scholar 

  85. Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene. 2002;21:1510–7.

    PubMed  CAS  Google Scholar 

  86. McGorray SP, Guo Y, Logan H. Trends in incidence of oral and pharyngeal carcinoma in Florida: 1981–2008. J Public Health Dent. 2012;72:68–74.

    PubMed Central  PubMed  Google Scholar 

  87. Golas SM. Trends in palatine tonsillar cancer incidence and mortality rates in the United States. Community Dent Oral Epidemiol. 2007;35:98–108.

    PubMed  Google Scholar 

  88. Forte T, Niu J, Lockwood GA, Bryant HE. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992–2009. Cancer Causes Control. 2012;23:1343–8.

    PubMed  Google Scholar 

  89. de Souza DL, de Camargo CM, Perez MM, Curado MP. Trends in the incidence of oral cavity and oropharyngeal cancers in Spain. Head Neck. 2012;34:649–54.

    PubMed  Google Scholar 

  90. Attner P, Du J, Nasman A, Hammarstedt L, Ramqvist T, Lindholm J, Marklund L, Dalianis T, Munck-Wikland E. The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer. 2010;126:2879–84.

    PubMed  CAS  Google Scholar 

  91. Ernster JA, Sciotto CG, O’Brien MM, Finch JL, Robinson LJ, Willson T, Mathews M. Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope. 2007;117:2115–28.

    PubMed  Google Scholar 

  92. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294–301.

    PubMed Central  PubMed  Google Scholar 

  93. D’Souza G, Zhang HH, D’Souza WD, Meyer RR, Gillison ML. Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer. Oral Oncol. 2010;46:100–4.

    PubMed Central  PubMed  Google Scholar 

  94. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261–9.

    PubMed  CAS  Google Scholar 

  95. Kingma DW, Allen RA, Moore W, Caughron SK, Melby M, Gillies EM, Marlar RA, Dunn ST. HPV genotype distribution in oral and oropharyngeal squamous cell carcinoma using seven in vitro amplification assays. Anticancer Res. 2010;30:5099–104.

    PubMed  Google Scholar 

  96. Mehanna H, Beech T, Nicholson T, El Hariry I, McConkey C, Paleri V, Roberts S. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck. 2013;35:747–55.

    Google Scholar 

  97. Brown LM, Check DP, Devesa SS. Oral cavity and pharynx cancer incidence trends by subsite in the United States: changing gender patterns. J Oncol. 2012;2012:649498.

    PubMed Central  PubMed  Google Scholar 

  98. El Mofty SK, Lu DW. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2003;27:1463–70.

    PubMed  Google Scholar 

  99. Cole L, Polfus L, Peters ES. Examining the incidence of human papillomavirus-associated head and neck cancers by race and ethnicity in the U.S., 1995–2005. PLoS One. 2012;7:e32657.

    PubMed Central  PubMed  CAS  Google Scholar 

  100. Brandsma JL, Abramson AL. Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg. 1989;115:621–5.

    PubMed  CAS  Google Scholar 

  101. Niedobitek G, Pitteroff S, Herbst H, Shepherd P, Finn T, Anagnostopoulos I, Stein H. Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil. J Clin Pathol. 1990;43:918–21.

    PubMed Central  PubMed  CAS  Google Scholar 

  102. Snijders PJ, Cromme FV, van den Brule AJ, Schrijnemakers HF, Snow GB, Meijer CJ, Walboomers JM. Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer. 1992;51:845–50.

    PubMed  CAS  Google Scholar 

  103. Smith EM, Pignatari SS, Gray SD, Haugen TH, Turek LP. Human papillomavirus infection in papillomas and nondiseased respiratory sites of patients with recurrent respiratory papillomatosis using the polymerase chain reaction. Arch Otolaryngol Head Neck Surg. 1993;119:554–7.

    PubMed  CAS  Google Scholar 

  104. Watanabe S, Ogura H, Fukushima K, Yabe Y. Comparison of Virapap filter hybridization with polymerase chain reaction and Southern blot hybridization methods for detection of human papillomavirus in tonsillar and pharyngeal cancers. Eur Arch Otorhinolaryngol. 1993;250:115–9.

    PubMed  CAS  Google Scholar 

  105. Fukushima K, Ogura H, Watanabe S, Yabe Y, Masuda Y. Human papillomavirus type 16 DNA detected by the polymerase chain reaction in non-cancer tissues of the head and neck. Eur Arch Otorhinolaryngol. 1994;251:109–12.

    PubMed  CAS  Google Scholar 

  106. Tominaga S, Fukushima K, Nishizaki K, Watanabe S, Masuda Y, Ogura H. Presence of human papillomavirus type 6f in tonsillar condyloma acuminatum and clinically normal tonsillar mucosa. Jpn J Clin Oncol. 1996;26:393–7.

    PubMed  CAS  Google Scholar 

  107. Strome SE, Savva A, Brissett AE, Gostout BS, Lewis J, Clayton AC, McGovern R, Weaver AL, Persing D, Kasperbauer JL. Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res. 2002;8:1093–100.

    PubMed  CAS  Google Scholar 

  108. Mammas IN, Sourvinos G, Michael C, Spandidos DA. Human papilloma virus in hyperplastic tonsillar and adenoid tissues in children. Pediatr Infect Dis J. 2006;25:1158–62.

    PubMed  Google Scholar 

  109. Sisk J, Schweinfurth JM, Wang XT, Chong K. Presence of human papillomavirus DNA in tonsillectomy specimens. Laryngoscope. 2006;116:1372–4.

    PubMed  CAS  Google Scholar 

  110. Chen R, Sehr P, Waterboer T, Leivo I, Pawlita M, Vaheri A, Aaltonen LM. Presence of DNA of human papillomavirus 16 but no other types in tumor-free tonsillar tissue. J Clin Microbiol. 2005;43:1408–10.

    PubMed Central  PubMed  CAS  Google Scholar 

  111. Duray A, Descamps G, Bettonville M, Sirtaine N, Ernoux-Neufcoeur P, Guenin S, Mouallif M, Depuydt CE, Delvenne P, Saussez S. High prevalence of high-risk human papillomavirus in palatine tonsils from healthy children and adults. Otolaryngol Head Neck Surg. 2011;145:230–5.

    PubMed  Google Scholar 

  112. do Sacramento PR, Babeto E, Colombo J, Cabral Ruback MJ, Bonilha JL, Fernandes AM, Pereira Sobrinho JS, de Souza FP, Villa LL, Rahal P. The prevalence of human papillomavirus in the oropharynx in healthy individuals in a Brazilian population. J Med Virol. 2006;78:614–8.

    PubMed  Google Scholar 

  113. Ernster JA, Sciotto CG, O’Brien MM, Robinson LJ, Willson T. Prevalence of oncogenic human papillomavirus 16 and 18 in the palatine tonsils of the general adult population. Arch Otolaryngol Head Neck Surg. 2009;135:554–7.

    PubMed  Google Scholar 

  114. Fouret P, Martin F, Flahault A, Saint-Guily JL. Human papillomavirus infection in the malignant and premalignant head and neck epithelium. Diagn Mol Pathol. 1995;4:122–7.

    PubMed  CAS  Google Scholar 

  115. Sikora AG, Morris LG, Sturgis EM. Bidirectional association of anogenital and oral cavity/pharyngeal carcinomas in men. Arch Otolaryngol Head Neck Surg. 2009;135:402–5.

    PubMed  Google Scholar 

  116. Frisch M, Biggar RJ. Aetiological parallel between tonsillar and anogenital squamous-cell carcinomas. Lancet. 1999;354:1442–43.

    PubMed  CAS  Google Scholar 

  117. Rose Ragin CC, Taioli E. Second primary head and neck tumor risk in cervical cancer patients—SEER data analysis. Head Neck. 2008;30:58–66.

    PubMed  Google Scholar 

  118. Crawford R, Grignon AL, Kitson S, Winder DM, Ball SL, Vaughan K, Stanley MA, Sterling JC, Goon PK. High prevalence of HPV in non-cervical sites of women with abnormal cervical cytology. BMC Cancer. 2011;11:473.

    PubMed Central  PubMed  Google Scholar 

  119. Hemminki K, Dong C, Frisch M. Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands. Eur J Cancer Prev. 2000;9:433–7.

    PubMed  CAS  Google Scholar 

  120. D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944–56.

    PubMed  Google Scholar 

  121. D’Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis. 2009;199:1263–9.

    PubMed  Google Scholar 

  122. Pickard RK, Xiao W, Broutian TR, He X, Gillison ML. The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18–30 years. Sex Transm Dis. 2012;39:559–66.

    PubMed  Google Scholar 

  123. Dahlstrom KR, Li G, Tortolero-Luna G, Wei Q, Sturgis EM. Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites. Head Neck. 2011;33:847–55.

    PubMed Central  PubMed  Google Scholar 

  124. Heck JE, Berthiller J, Vaccarella S, Winn DM, Smith EM, Shan’gina, O., Schwartz SM, Purdue MP, Pilarska A, Eluf-Neto J, Menezes A, McClean MD, Matos E, Koifman S, Kelsey KT, Herrero R, Hayes RB, Franceschi S, Wunsch-Filho V, Fernandez L, Daudt AW, Curado MP, Chen C, Castellsague X, Ferro G, Brennan P, Boffetta P, Hashibe M. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol. 2010;39:166–81.

    PubMed Central  PubMed  Google Scholar 

  125. Rischin D, Young RJ, Fisher R, Fox SB, Le QT, Peters LJ, Solomon B, Choi J, O’Sullivan B, Kenny LM, McArthur GA. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol. 2010;28:4142–48.

    PubMed Central  PubMed  CAS  Google Scholar 

  126. Young RJ, Rischin D, Fisher R, McArthur GA, Fox SB, Peters LJ, Corry J, Lim A, Waldeck K, Solomon B. Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2011;20:1230–7.

    PubMed  CAS  Google Scholar 

  127. Hoff CM, Lassen P, Eriksen JG, Hansen HS, Specht L, Overgaard M, Grau C, Johansen J, Bentzen J, Andersen L, Evensen JF, Overgaard J. Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? – results from the randomized DAHANCA 5 and 7 trials. Acta Oncol. 2011;50:1006–14.

    PubMed  CAS  Google Scholar 

  128. Jo S, Juhasz A, Zhang K, Ruel C, Loera S, Wilczynski SP, Yen Y, Liu X, Ellenhorn J, Lim D, Paz B, Somlo G, Vora N, Shibata S. Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial. Anticancer Res. 2009;29:1467–74.

    PubMed Central  PubMed  CAS  Google Scholar 

  129. Kies MS, Holsinger FC, Lee JJ, William WN, Jr., Glisson BS, Lin HY, Lewin JS, Ginsberg LE, Gillaspy KA, Massarelli E, Byers L, Lippman SM, Hong WK, el Naggar AK, Garden AS, Papadimitrakopoulou V. Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. J Clin Oncol. 2010;28:8–14.

    PubMed Central  PubMed  CAS  Google Scholar 

  130. Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol. 2009;27:1992–8.

    Google Scholar 

  131. Posner MR, Lorch JH, Goloubeva O, Tan M, Schumaker LM, Sarlis NJ, Haddad RI, Cullen KJ. Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial. Ann Oncol. 2011;22:1071–7.

    PubMed  CAS  Google Scholar 

  132. Quon H, Cohen MA, Montone KT, Ziober A, Wang LP, Weinstein GS, O’Malley BW Jr. Transoral robotic surgery and adjuvant therapy for oropharyngeal carcinomas and the influence of p16(INK4a)on treatment outcomes. Laryngoscope. 2013;123(3):635–40.

    PubMed  Google Scholar 

  133. Ragin CC, Taioli E, Weissfeld JL, White JS, Rossie KM, Modugno F, Gollin SM. 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. Br J Cancer. 2006;95:1432–8.

    PubMed Central  PubMed  CAS  Google Scholar 

  134. Smeets SJ, Braakhuis BJ, Abbas S, Snijders PJ, Ylstra B, van de Wiel MA, Meijer GA, Leemans CR, Brakenhoff RH. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Oncogene. 2006;25:2558–64.

    PubMed  CAS  Google Scholar 

  135. Schlecht NF, Burk RD, Adrien L, Dunne A, Kawachi N, Sarta C, Chen Q, Brandwein-Gensler M, Prystowsky MB, Childs G, Smith RV, Belbin TJ. Gene expression profiles in HPV-infected head and neck cancer. J Pathol. 2007;213:283–93.

    PubMed  CAS  Google Scholar 

  136. Slebos RJ, Yi Y, Ely K, Carter J, Evjen A, Zhang X, Shyr Y, Murphy BM, Cmelak AJ, Burkey BB, Netterville JL, Levy S, Yarbrough WG, Chung CH. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res. 2006;12:701–9.

    PubMed  CAS  Google Scholar 

  137. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24–35.

    PubMed Central  PubMed  CAS  Google Scholar 

  138. Granata R, Miceli R, Orlandi E, Perrone F, Cortelazzi B, Franceschini M, Locati LD, Bossi P, Bergamini C, Mirabile A, Mariani L, Olmi P, Scaramellini G, Potepan P, Quattrone P, Ang KK, Licitra L. Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer:an Italian validation study. Ann Oncol. 2012;23:1832–7.

    PubMed  CAS  Google Scholar 

  139. Settle K, Posner MR, Schumaker LM, Tan M, Suntharalingam M, Goloubeva O, Strome SE, Haddad RI, Patel SS, Cambell EV, III, Sarlis N, Lorch J, Cullen KJ. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila Pa). 2009;2:776–81.

    Google Scholar 

  140. Chernock RD, Zhang Q, El Mofty SK, Thorstad WL, Lewis JS Jr. Human papillomavirus-related squamous cell carcinoma of the oropharynx: a comparative study in whites and African Americans. Arch Otolaryngol Head Neck Surg. 2011;137:163–9.

    Google Scholar 

  141. Worsham MJ, Stephen JK, Chen KM, Mahan M, Schweitzer V, Havard S, et al. Improved survival with HPV among African Americans with oropharyngeal cancer. Clin Cancer Res 2013;19(9):2486–92.

    Google Scholar 

  142. Worsham MJ, Stephen JK, Chen KM, Mahan M, Havard S, Divine G. Improved Survival with HPV Among African Americans with Oropharyngeal Cancer. 8th International Conference in Head and Neck Cancer; 2012.

    Google Scholar 

  143. Jayaprakash V, Reid M, Hatton E, Merzianu M, Rigual N, Marshall J, Gill S, Frustino J, Wilding G, Loree T, Popat S, Sullivan M. Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985–2010. Oral Oncol. 2011;47:1048–54.

    PubMed Central  PubMed  Google Scholar 

  144. Syrjanen S, Lodi G, von, B., I, Aliko A, Arduino P, Campisi G, Challacombe S, Ficarra G, Flaitz C, Zhou HM, Maeda H, Miller C, Jontell M. Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis. 2011;17(Suppl 1):58–72.

    PubMed  Google Scholar 

  145. Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, Thomas SJ. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol. 2006;31:259–66.

    PubMed  CAS  Google Scholar 

  146. Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer. 2007;110:1429–35.

    PubMed  Google Scholar 

  147. Brown LM. Epidemiology of alcohol-associated cancers. Alcohol. 2005;35:161–8.

    PubMed  Google Scholar 

  148. Trends in Tobacco Use. American Lung Association Research and Program Services, Epidemiology and Statistics Unit, Epidemiology and Statistics Unit Assessed. 2012. (Ref Type: Electronic Citation).

    Google Scholar 

  149. LaVallee RA, Yi, H-Y. Apparent per capita alcohol consumption: national, state, and regional trends, 1977–2009. Surveillance Report #92, National Institute on Alcohol Abuse and Alcoholism Division of Epidemiology and Prevention Research Alcohol Epidemiologic Data System. 2012.

    Google Scholar 

  150. US Department of Health and Human Services. Preventing tobacco use among young people: a report of the surgeon general. 1994. Atlanta, Ga, S Dept of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking on Health.

    Google Scholar 

  151. Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20–44 years. Cancer. 2005;103:1843–9.

    PubMed  Google Scholar 

  152. Muller S, Pan Y, Li R, Chi AC. Changing trends in oral squamous cell carcinoma with particular reference to young patients: 1971–2006. The Emory University experience. Head Neck Pathol. 2008;2:60–6.

    PubMed Central  PubMed  Google Scholar 

  153. Schantz SP, Yu GP. Head and neck cancer incidence trends in young Americans, 1973–1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg. 2002;128:268–74.

    PubMed  Google Scholar 

  154. Saba NF, Goodman M, Ward K, Flowers C, Ramalingam S, Owonikoko T, Chen A, Grist W, Wadsworth T, Beitler JJ, Khuri FR, Shin DM. Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and end results program-based analysis. Oncology. 2011;81:12–20.

    PubMed Central  PubMed  Google Scholar 

  155. Fast Stats: An interactive tool for access to SEER cancer statistics. 2013. Surveillance Research Program, National Cancer Institute. http://seer.cancer.gov/faststats. Accessed: 16. Jan. 2013. (Ref Type: Generic).

  156. Seraj JM, Yazdani N, Ashtiani ZO, Seraj SM, Hasheminasab SM, Memar B, Mirashrafi F, Borghei H, Yazdani J, Mostaan LV. TP53 gene expression in HPV-positive oral tongue SCC and its correlation with nodal metastasis. Pathol Res Pract. 2011;207:758–61.

    PubMed  CAS  Google Scholar 

  157. Elango KJ, Suresh A, Erode EM, Subhadradevi L, Ravindran HK, Iyer SK, Iyer SK, Kuriakose MA. Role of human papilloma virus in oral tongue squamous cell carcinoma. Asian Pac J Cancer Prev. 2011;12:889–96.

    PubMed  Google Scholar 

  158. Lingen MW, Xiao W, Schmitt A, Jiang B, Pickard R, Kreinbrink P, Perez-Ordonez B, Jordan RC, Gillison ML. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol. 2013;49(1):1–8.

    PubMed  Google Scholar 

  159. Duray A, Descamps G, Decaestecker C, Remmelink M, Sirtaine N, Lechien J, Ernoux-Neufcoeur P, Bletard N, Somja J, Depuydt CE, Delvenne P, Saussez S. Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma. Laryngoscope. 2012;122:1558–65.

    PubMed  CAS  Google Scholar 

  160. Isayeva T, Li Y, Maswahu D, Brandwein-Gensler M. Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol. 2012;6(Suppl 1):S104–120.

    PubMed  Google Scholar 

  161. Li X, Li H, Gao J, Yang Y, Zhou F, Gao C, Li M, Jin Q, Gao L. Human Papillomavirus Infection and Laryngeal Cancer Risk: a systematic review and meta-analysis. J Infect Dis. 2013;207:479–88.

    Google Scholar 

  162. Wilson DD, Rahimi AS, Saylor DK, Stelow EB, Jameson MJ, Shonka DC, Reibel JF, Levine PA, Read PW. p16 not a prognostic marker for hypopharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2012;138:556–61.

    PubMed  Google Scholar 

  163. Stephen JK, Chen KM, Shah V, Havard S, Lu M, Schweitzer VP, Gardner G, Worsham MJ. Human papillomavirus outcomes in an access-to-care laryngeal cancer cohort. Otolaryngol Head Neck Surg. 2012;146:730–8.

    PubMed Central  PubMed  Google Scholar 

  164. Duray A, Descamps G, Arafa M, Decaestecker C, Remmelink M, Sirtaine N, Ernoux-Neufcoeur P, Mutijima E, Somja J, Depuydt CE, Delvenne P, Saussez S. High incidence of high-risk HPV in benign and malignant lesions of the larynx. Int J Oncol. 2011;39:51–9.

    PubMed  Google Scholar 

  165. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010;401:70–9.

    PubMed Central  PubMed  CAS  Google Scholar 

  166. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur HH. Classification of papillomaviruses. Virology. 2004;324:17–27.

    Google Scholar 

  167. Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA. Family Papillomaviridae. Virus taxonomy. The Eight Report of the International Committee on Taxonomy of Viruses. 239–255. Elsevier;2005.

    Google Scholar 

  168. Chen Z, Terai M, Fu L, Herrero R, Desalle R, Burk RD. Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J Virol. 2005;79:7014–23.

    PubMed Central  PubMed  CAS  Google Scholar 

  169. Ho L, Chan SY, Burk RD, Das BC, Fujinaga K, Icenogle JP, Kahn T, Kiviat N, Lancaster W, Mavromara-Nazos P, and. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol. 1993;67:6413–23.

    Google Scholar 

  170. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, Wheeler CM. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol. 1997;71:2463–72.

    PubMed Central  PubMed  CAS  Google Scholar 

  171. Ong CK, Chan SY, Campo MS, Fujinaga K, Mavromara-Nazos P, Labropoulou V, Pfister H, Tay SK, ter Meulen J, Villa LL, and. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol., 67:6424–6431, 1993.

    PubMed Central  PubMed  CAS  Google Scholar 

  172. Chen Z, Schiffman M, Herrero R, Desalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD. Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One. 2011;6:e20183.

    PubMed Central  PubMed  CAS  Google Scholar 

  173. Chen Z, Desalle R, Schiffman M, Herrero R, Burk RD. Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97. J Virol. 2009;83:1443–55.

    PubMed Central  PubMed  CAS  Google Scholar 

  174. Durst M, Gissmann L, Ikenberg H, zur HH. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U.S.A. 1983;80:3812–5.

    Google Scholar 

  175. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur HH. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 1984;3:1151–7.

    Google Scholar 

  176. Xi LF, Carter JJ, Galloway DA, Kuypers J, Hughes JP, Lee SK, Adam DE, Kiviat NB, Koutsky LA. Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students. Cancer Epidemiol Biomarkers Prev. 2002;11:343–51.

    PubMed  Google Scholar 

  177. Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, Franco EL. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol. 2000;81:2959–68.

    PubMed  CAS  Google Scholar 

  178. Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez A, Bratti MC, Sherman ME, Scarpidis U, Lin QQ, Terai M, Bromley RL, Buetow K, Apple RJ, Burk RD. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst. 2001;93:315–8.

    PubMed  CAS  Google Scholar 

  179. Berumen J, Ordonez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, Yunes E, Garcia-Carranca A, Gonzalez-Lira G, Madrigal-de la Campa A. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst. 2001;93:1325–30.

    PubMed  CAS  Google Scholar 

  180. Refugio Gonzalez-Losa M, Laviada M, Puerto-Solis M, Garcia-Carranca A. Molecular variants of HPV type 16 E6 among Mexican women with LSIL and invasive cancer. J Clin Virol. 2004;29:95–8.

    Google Scholar 

  181. Xi LF, Critchlow CW, Wheeler CM, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Hawes SE, Surawicz C, Goldbaum G, Holmes KK, Kiviat NB. Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants. Cancer Res. 1998;58:3839–44.

    PubMed  CAS  Google Scholar 

  182. Xi LF, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Wheeler CM, Holmes KK, Kiviat NB. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst. 1997;89:796–802.

    PubMed  CAS  Google Scholar 

  183. Matsumoto K, Yoshikawa H, Nakagawa S, Tang X, Yasugi T, Kawana K, Sekiya S, Hirai Y, Kukimoto I, Kanda T, Taketani Y. Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population. Cancer Lett. 2000;156:159–65.

    PubMed  CAS  Google Scholar 

  184. Xi LF, Koutsky LA, Hildesheim A, Galloway DA, Wheeler CM, Winer RL, Ho J, Kiviat NB. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev. 2007;16:4–10.

    PubMed  CAS  Google Scholar 

  185. Stoppler MC, Ching K, Stoppler H, Clancy K, Schlegel R, Icenogle J. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol. 1996;70:6987–93.

    PubMed Central  PubMed  CAS  Google Scholar 

  186. Cruz-Hernandez E, Garcia-Carranca A, Mohar-Betancourt A, Duenas-Gonzalez A, Contreras-Paredes A, Perez-Cardenas E, Herrera-Goepfert R, Lizano-Soberon M. Differential splicing of E6 within human papillomavirus type 18 variants and functional consequences. J Gen Virol. 2005;86:2459–68.

    PubMed  Google Scholar 

  187. Chakrabarti O, Veeraraghavalu K, Tergaonkar V, Liu Y, Androphy EJ, Stanley MA, Krishna S. Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras. J Virol. 2004;78:5934–45.

    PubMed Central  PubMed  CAS  Google Scholar 

  188. Contreras-Paredes A, Cruz-Hernandez E, Martinez-Ramirez I, Duenas-Gonzalez A, Lizano M. E6 variants of human papillomavirus 18 differentially modulate the protein kinase B/phosphatidylinositol 3-kinase (akt/PI3K) signaling pathway. Virology. 2009;383:78–85.

    PubMed  CAS  Google Scholar 

  189. Veress G, Szarka K, Dong XP, Gergely L, Pfister H. Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. J Gen Virol. 1999;80(Pt 4):1035–43.

    PubMed  CAS  Google Scholar 

  190. Kammer C, Tommasino M, Syrjanen S, Delius H, Hebling U, Warthorst U, Pfister H, Zehbe I. Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease. Br J Cancer. 2002;86:269–73.

    PubMed Central  PubMed  CAS  Google Scholar 

  191. Park JS, Hwang ES, Lee CJ, Kim CJ, Rha JG, Kim SJ, Namkoong SE, Um SJ. Mutational and functional analysis of HPV-16 URR derived from Korean cervical neoplasia. Gynecol Oncol. 1999;74:23–9.

    Google Scholar 

  192. May M, Dong XP, Beyer-Finkler E, Stubenrauch F, Fuchs PG, Pfister H. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J. 1994;13:1460–6.

    PubMed Central  PubMed  CAS  Google Scholar 

  193. Rose B, Steger G, Dong XP, Thompson C, Cossart Y, Tattersall M, Pfister H. Point mutations in SP1 motifs in the upstream regulatory region of human papillomavirus type 18 isolates from cervical cancers increase promoter activity. J Gen Virol. 1998;79(Pt 7):1659–63.

    PubMed  CAS  Google Scholar 

  194. Hubert WG Variant upstream regulatory region sequences differentially regulate human papillomavirus type 16 DNA replication throughout the viral life cycle. J Virol. 2005;79:5914–22.

    Google Scholar 

  195. Du J, Nordfors C, Nasman A, Sobkowiak M, Romanitan M, Dalianis T, Ramqvist T. Human papillomavirus (HPV) 16 E6 variants in tonsillar cancer in comparison to those in cervical cancer in Stockholm, Sweden. PLoS One. 2012;7:e36239.

    PubMed Central  PubMed  CAS  Google Scholar 

  196. Boscolo-Rizzo P, Da Mosto MC, Fuson R, Frayle-Salamanca H, Trevisan R, Del Mistro A. HPV-16 E6 L83V variant in squamous cell carcinomas of the upper aerodigestive tract. J Cancer Res Clin Oncol. 2009;135:559–66.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Prevention and Control Program, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, USA

    Camille C. R. Ragin PhD, MPH

  2. Department of Otolaryngology, Fox Chase Cancer Center, Temple University, Philadelphia, PA, USA

    Jeffrey C. Liu MD

Authors
  1. Camille C. R. Ragin PhD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeffrey C. Liu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Camille C. R. Ragin PhD, MPH .

Editor information

Editors and Affiliations

  1. Developmental Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA

    Barbara Burtness

  2. Developmental Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA

    Erica A. Golemis

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ragin, C., Liu, J. (2014). Epidemiology of HPV in Head and Neck Cancer: Variant Strains, Discrete Protein Function. In: Burtness, B., Golemis, E. (eds) Molecular Determinants of Head and Neck Cancer. Current Cancer Research. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8815-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8815-6_3

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8814-9

  • Online ISBN: 978-1-4614-8815-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation